SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
1-Year Return
17.43%
This Quarter Return
+12.51%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.47B
AUM Growth
+$144M
(+11%)
Cap. Flow
+$51.7M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
55.99%
Holding
73
New
9
Increased
18
Reduced
18
Closed
13
Top Buys
1 |
Gilead Sciences
GILD
|
$70M |
2 |
AbbVie
ABBV
|
$49.3M |
3 |
Boston Scientific
BSX
|
$46.3M |
4 |
Eli Lilly
LLY
|
$34.5M |
5 |
United Therapeutics
UTHR
|
$34.1M |
Top Sells
1 |
Stryker
SYK
|
$111M |
2 |
Medtronic
MDT
|
$50.6M |
3 |
Alnylam Pharmaceuticals
ALNY
|
$47.6M |
4 |
BPMC
Blueprint Medicines
BPMC
|
$23.1M |
5 |
Bristol-Myers Squibb
BMY
|
$22.7M |
Sector Composition
1 | Healthcare | 100% |